Shares of Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) surged more than 16% in Tuesday’s morning trade after the manufacturer and marketer of pharmaceutical and health supplement products in China announced the upcoming launch of its “Easy Breathing” product for the treatment of rhinitis and sinusitis. The product will be manufactured, distributed and sold in the People’s Republic of China, where the company is based. Sales will commence in November 2016. Rhinitis is irritation and inflammation of the mucous membrane inside the nose. Sinusitis is an inflammation or swelling of the tissue lining the sinuses.
To view the full press release, visit: http://nnw.fm/ImyW6
About Biostar Pharmaceuticals, Inc.
Biostar Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. For more information visit www.biostarpharmaceuticals.com
NetworkNewsBreak is a rapid summary of a press release that caught the attention of NetworkNewsWire (NNW). NNW provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing network of more than 5,000 key distribution outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge. For more information, visit https://www.NetworkNewsWire.com.
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer